3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Stomach Neoplasms
3
Malnutrition
2
Carcinoma, Hepatocellular
2
Psychological Well-Being
1
Motor Activity
1
Lung Neoplasms
1
Liver Cirrhosis
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Esophageal Neoplasms
1
Endotoxemia
1
Diarrhea
1
Anus Neoplasms
1
Adenomatous Polyposis Coli
1
Interventions
Fluorouracil
26
Radiotherapy
18
Mitomycin
17
Cisplatin
12
Capecitabine
12
pembrolizumab
10
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
9
Radiation
8
Paclitaxel
8
Biopsy
8
fludarabine
7
Specimen Handling
7
Nivolumab
7
Drug Therapy
7
Carboplatin
7
Surveys and Questionnaires
6
Cetuximab
6
Papillomavirus Vaccines
5
dehydroftorafur
4
aldesleukin
4
Vaccines
4
Radiotherapy, Intensity-Modulated
4
Observation
4
Irinotecan
4
Watchful Waiting
3
Taxes
3
Oxaliplatin
3
Light Coagulation
3
Ipilimumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Probiotics
×
Gastrointestinal
×
Clear all
NCT03870607
2023-01-17
BISQUIT
AC Camargo Cancer Center
Phase 2
Unknown
75 enrolled